Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
Amgen
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
PedAL BCU, LLC
AstraZeneca
Sumitomo Pharma America, Inc.
Syndax Pharmaceuticals
University of Chicago
AstraZeneca
Chinese PLA General Hospital
National Institutes of Health Clinical Center (CC)
Beijing GoBroad Hospital
National Institutes of Health Clinical Center (CC)
Ossium Health, Inc.
MSD R&D (China) Co., Ltd.
University of Alberta
BIOHENG THERAPEUTICS US LLC
Memorial Sloan Kettering Cancer Center
Stanford University
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Bambino Gesù Hospital and Research Institute
Beijing GoBroad Hospital
Beijing GoBroad Hospital
Kura Oncology, Inc.
Fred Hutchinson Cancer Center
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Ottawa Hospital Research Institute
Essen Biotech
Zhujiang Hospital
Chinese PLA General Hospital
Case Comprehensive Cancer Center
The First Affiliated Hospital of Soochow University
Instituto Nacional de Cancer, Brazil
University of Sao Paulo
University Hospital Heidelberg
Assistance Publique - Hôpitaux de Paris
Shenzhen TargetRx Co., Ltd.